Defects in genes encoding the isoforms of the laminin alpha subunit have been linked to various phenotypic manifestations, including brain malformations, muscular dystrophy, ocular defects, cardiomyopathy, and skin abnormalities. We report here a severe defect of neuromuscular transmission in a consanguineous patient with a homozygous variant in the laminin alpha-5 subunit gene (LAMA5). The variant c.8046C>T (p.Arg2659Trp) is rare and has a predicted deleterious effect. The affected individual, who also carries a rare homozygous sequence variant in LAMA1, had muscle weakness, myopia, and facial tics. Magnetic resonance imaging of brain showed mild volume loss and periventricular T2 prolongation. Repetitive nerve stimulation revealed 50% decrement of compound muscle action potential amplitudes and 250% facilitation immediately after exercise, Endplate studies identified a profound reduction of the endplate potential quantal content and endplates with normal postsynaptic folding that were denuded or partially occupied by small nerve terminals. Expression studies revealed that p.Arg2659Trp caused decreased binding of laminin alpha-5 to SV2A and impaired laminin-521 cell-adhesion and cell projection support in primary neuronal cultures. In summary, this report describing severe neuromuscular transmission failure in a patient with a LAMA5 mutation expands the list of phenotypes associated with defects in genes encoding alpha-laminins.
and -γ1 in laminins α2β2γ1, α4β2γ1, and α5β2γ1 is essential for the neuromuscular junction (NMJ) since these are the only laminin variants selectively expressing at the small portion of the basal lamina that covers the adult motor endplate (Patton, Miner, Chiu, & Sanes, 1997) .
Laminin β2 plays a fundamental role in the organization of the NMJ. Mice lacking laminin β2 appear normal at birth, but later develop progressive weakness and proteinuria and die within the first weeks of life (Noakes, Gautam, Mudd, Sanes, & Merlie, 1995) .
Laminin α4 appears to play a role in the precise alignment of preand postsynaptic specialized structures since α4-deficient mice show a peculiar loss of precise apposition of presynaptic active zones to secondary synaptic clefts at the NMJ (Patton et al., 2001 ).
The role that laminin α5 plays at the NMJ has been difficult to establish because mice lacking laminin α5 die at late embryonic stages due to multiple developmental abnormalities and placental insufficiency (Miner, Cunningham, & Sanes, 1998 ).
However, a conditional mutant where laminin α5 was selectively removed showed delay of postsynaptic maturation and complete arrest of postsynaptic development was observed in double mutants lacking laminins α4 and α5 (Nishimune et al., 2008) . Importantly, in spite that the conditional laminin α5 mouse does not display any overt phenotype, presynaptic differentiation appears to be primarily affected since in this animal model motor nerves only partially cover the postsynaptic membrane during the initial period of postnatal development.
We describe here an individual with a severe CMS attributed to a homozygous mutation in the gene encoding the laminin α5 subunit (LAMA5) (MIM 601033), which showed selective presynaptic ultrastructural changes of the NMJ reminiscent of those found at early stages of differentiation in the conditional Lama5 mutant mouse.
| CLINICAL REPORT
The proband is a 24-year-old woman who was born full-term to a consanguineous couple of second cousins. She was born hypotonic with weak sucking and crying, but no arthrogryposis was noted at birth. After birth she required tracheostomy and mechanical ventilation for respiratory failure and at the age of 13, she underwent corrective surgery for severe scoliosis. She had weakness that worsened with respiratory infections but she had no episodes of dyspnea or apnea. Currently, she requires mechanical ventilation for most parts of the day and gastric tube for feeding. Her parents and three siblings are healthy, but an older brother died of muscle weakness and respiratory failure. Serum creatinine was normal and antibodies against the acetylcholine receptor (AChR) and the muscle specific kinase (MuSK) were negative. A recent physical examination showed minor dysmorphic features including elongated face, elevated hard palate, and mild facial and body hirsutism (Supporting Information Figure S1 ). Her mentation was normal, but the cranial nerve examination revealed bilateral ptosis, and weakness of the bilateral inferior oblique, facial, tongue, and soft palate muscles. She also had facial tics Table S1 ). A brain MRI revealed mild volume loss for age and periventricular T2 prolongation (Figure 1a,b) . Repetitive stimulation of the right spinal accessory nerve at 2 Hz revealed 55% decrement of the compound muscle action potential (CMAP)
amplitudes. There was severe reduction of CMAP amplitudes with more than 250% increment of CMAP amplitudes immediately after 30 s of maximal muscle activation (Figure 1c,d) .
To study the mechanism of failure of neuromuscular transmission we performed an anconeus muscle biopsy at age 7, which included microelectrode recordings and electron microscopy (EM) of the NMJ as previously described (Maselli, Mass, Distad, & Richman, 1991) . Light microscopy revealed mild angular atrophy of type II fibers and type I predominance.
Microelectrode recordings showed severe reduction of the average quantal content of end plate potentials (EPPs) evoked by nerve stimulation at 1 Hz, which was largely due to the fact that at most endplates, nerve stimulation failed to elicit EPPs (Supporting Information Table S2 ). The averaged EPP quantal content of 2.14 ± 0.74 calculated at three endplates after the perfusion of the muscle with 250 μM 3,4 diaminopyridine (3,4 DAP) was about four times higher than the average EPP quantal content of 0.54 ± 0.21 calculated at seven endplates before the addition of 3,4 DAP. In contrast with the severe abnormalities of the EPPs the amplitudes, frequencies and decay time constants of miniature endplate potentials (MEPPs) were normal.
The most distinctive findings of the electron microscopy (EM) of the NMJ were: (1) Table S4 ), but only the variants in LAMA1 (rs532162048), p.Asp210Asn; and LAMA5 (rs201012962), p.Arg2659Trp, were considered potentially relevant as the other genes did not appear to play a direct role in synaptic transmission (Supporting Information   Table S5 ). Both variants were present in the parents in the heterozygous state and absent in the non-affected sister (DNA from two brothers was not available). The homozygous variant in LAMA1 (MIM 615960) was considered unlikely to be causal of the CMS because the protein product of LAMA1, laminin α1, is not expressed at the adult NMJ, and because biallelic mutations in LAMA1 are associated with the so-called Poretti-Boltshauser syndrome (PBS), which does not comprise neuromuscular involvement (Aldinger et al., 2014) . Moreover, other frequent clinical features of PBS, such as cerebellar dysplasia with cysts, and retinal dystrophy were not present in the proband. Nevertheless, we cannot rule out that some of the clinical features of our patient, including, myopia, facial tics, and brain MRI abnormalities, which have previously been described in PBS (Vilboux et al., 2016) , may result from the LAMA1 variation.
The p.Arg2659Trp substitution in LAMA5, located in the domain II of the protein involved in the coil-coiled structure, was considered a priority candidate variant because it is rare (maximum alternate allele frequency in any subpopulation in ExAC = 0.00044), is relatively conserved in mammals (Supporting Information Figure S2) , and is predicted to be damaging by PolyPhen-2 HumVar (score = 0.978), SIFT (score = 0.001), and CADD v1.3 (score = 24.9). Furthermore, laminin α5 expresses at the embryonic and adult NMJ, and a conditional mouse mutant where laminin α5 is removed shows developmental abnormalities of the NMJ (Nishimune et al., 2008) .
To elucidate the effect of p.Arg2659Trp, we introduced it in a human laminin α5 clone and tested its impact in three important biological process involving laminins: signaling, cell adhesion, and neurite outgrowth support.
Laminins containing the α5 form a high affinity complex with the SV protein SV2 (Son et al., 2000) , which in turn binds to synaptotagmin, a Ca 2+ sensor protein that is implicated in SV exocytosis (Schivell, Batchelor, & Bajjalieh, 1996) . It is also thought that the SV2/laminin α5 complex may help define sites of vesicle retrieval for endocytosis (Carlson, Valdez, & Sanes, 2010) . Thus, giving the important role that the SV2/laminin α5 interaction may play in SV trafficking we tested the binding of LAMA5 p.Arg2659Trp to SV2A using dot blotting as previously described (Arredondo et al., 2014) . Figure 2a 
| DISCUSSION
The deficient support of cell adhesion and neurite outgrowth by the mutant laminin α5 provides a plausible explanation for the ultrastructural findings of underdeveloped nerve terminals observed at the NMJs of the patient. However, since laminin α5 is widely expressed in adult tissues, it is unclear why the proband's phenotype does not include abnormalities of other organs such as the lung, heart, and kidneys that have the highest levels of expression of laminin α5.
The selective involvement of the NMJ in our case may be accounted by two separate, but not mutually exclusive explanations.
The first explanation is that a defective laminin alpha-5 may be sufficient to provide effective ECM support to tissues like lung, heart, and kidneys, but may fail to maintain normal function at more active metabolic sites such as at the NMJ. This interpretation is supported by the finding that in the conditional laminin alpha-5 mouse model, none of the defects observed in knockout embryos (e.g., exencephaly, and abnormalities in craniofacial anatomy, lung, kidney, and hair) are observed (Nishimune et al., 2008) . Nevertheless, in this model there is marked developmental delay of the NMJ, which suggests that the NMJ is particularly vulnerable to defects of laminin α5. The second explanation is that a defective laminin α5 may affect a fundamental signaling pathways operating at the NMJ but not in other tissues.
While the interaction between laminin α5 with its primary receptor integrin α3β1 takes place at many organs, including lung, kidney, and skin (Kikkawa, Sanzen, & Sekiguchi, 1998; Pouliot, Saunders, & Kaur, 2002) the interaction between laminin α5 with SV2A and synaptotagmin via SVA2A is restricted to the NMJ.
Laminins containing the α5 subunit bind to the luminal domain of SV2, presumably at highly conserved N-linked glycosylation sites.
After fusion of the SV to the presynaptic membrane the luminal side of the vesicle becomes exposed to the ECM enabling the interaction of SV2 with laminin α5. This interaction may provide an activitydependent mechanism for anchoring the presynaptic membrane to the ECM, particularly during early stages of nerve development and regeneration (Son et al., 2000) . Thus, an impaired interaction of the mutant laminin α5 with SV2A may explain the underdeveloped nerve terminals seen in this patient, but not the modest signs of central nervous system involvement found in this patient. Furthermore, given the multiple interactions of laminin α5 with other proteins a complete expression study would require the analysis of the interaction with many other proteins of the NMJ The other presynaptic deficit observed in our patient involved a reduction of the probability of release similar to that observed in the Lambert Eaton Myasthenic Syndrome (LEMS) (García, Mynlieff, Sanders, Beam, & Walrond, 1996) . The underlying LEMS-like defect in our patient, similar to that seen in recently described CMS (Supporting Information Table S6 ), was supported by three different lines of evidence. First, there was an increase of more than 250% of the CMAP amplitude immediately after exercise similar to that seen in LEMS. Second, there was a 400% increased of EPP quantal content after exposure of the anconeus muscle in vitro to 3,4 DAP. Third, there was an excellent clinical response to 3,4 DAP.
A disruption of the interaction of laminin α5 with SV2A may also explain the LEMS-like defect as several studies have proposed that the SV2 isoforms regulate presynaptic Ca 2+ dynamics, (Chang & Südhof, 2009; Janz et al., 1999) which has direct impact on the probability of SV release. Furthermore, the N-terminal region of the three SV2 isoforms binds to synaptotagmin-1, which is a Ca 2+ sensor protein primarily involved in SV exocytosis (Perin et al., 1991) .
In summary, we identified homozygous variants in LAMA5 and LAMA1 in a patient with a complex phenotype reminiscent of PBS, except for the presence of severe failure of neuromuscular transmission due to the LAMA5 mutation that reduces binding of laminin α5 to SV2A and laminin 521 support of cell adhesion and cell outgrowth. This results in a severe CMS characterized by underdeveloped nerve terminals and a severe presynaptic failure of neuromuscular transmission. The condition responds well to a combined treatment with pyridostigmine sulfate and 3,4 DAP.
